Early technology assessment of new medical devices

International Journal of Technology Assessment in Health Care

Volumn 24, Issue 1, 2008, Pages 36-44

  Pietzsch, Jan B ^a,b,c,d   Paté Cornell, M Elisabeth ^a,c  

^a STANFORD UNIVERSITY   (United States)

^b YesTech Inc   (United States)

^c Stanford University   (United States)

^d Wing Tech Inc   (United States)

Author keywords

Commercialization; Decision support; Medical device; Performance; Probability; Risk; Technology assessment

Indexed keywords

DECISION MAKING; PROBABILITY DISTRIBUTIONS; QUALITY ASSURANCE; RISK ASSESSMENT; TECHNOLOGY TRANSFER;

COMMERCIALIZATION; DECISION SUPPORT; PERFORMANCE ANALYSIS; TECHNOLOGY ASSESSMENT;

BIOMEDICAL EQUIPMENT;

ARTICLE; BIOMEDICAL ENGINEERING; DECISION SUPPORT SYSTEM; MEDICAL INSTRUMENTATION; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK REDUCTION; STROKE; UNITED STATES;

COMMERCE; DECISION MAKING, ORGANIZATIONAL; EQUIPMENT AND SUPPLIES; MODELS, ORGANIZATIONAL; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UNITED STATES;

EID: 38549125986     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462307080051     Document Type: Article

References (27)

1. Barnett HJM, Eliasziw M, Meldrum HE. Drugs and surgery in the prevention of ischemic stroke. N Engl J Med. 1995;332:238-248.
2. Benjamin JR, Cornell CA. Probability, statistics, and decision for civil engineers. New York: McGraw-Hill; 1970.
3. Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death - The Framingham Heart Study. Circulation. 1998;98:946-952.
4. Berry DA. Using a Bayesian approach in medical device development. Publication for the U.S. Federal Food and Drug Administration's Center for Devices and Radiological Health, Institute of Statistics & Decision Sciences and Comprehensive Cancer Center. Durham, NC: Duke University; 1997.
5. Buxton M. Early assessment of health technologies - The state of the science. Presentation at CCOHTA/Euroscan Symposium 'Early Assessment of Health Technologies'. Ottawa, Canada: October 12, 2000.
6. CCOHTA. CCOHTA/Euroscan Symposium on 'Early Assessment of Health Technologies'. Conference Summary. Ottawa, Canada: Canadian Coordinating Office for Health Technology Assessment; 2000.
7. Clemen RT. Combining forecasts: A review and annotated bibliography. Int J Forecast. 1989;5:559-583.
8. Clemen RT, Winkler RL. Combining probability distributions from experts in risk analysis. Risk Anal. 1999;19:187-203.
9. Clemens PL. Making component failure probability estimates. Tutorial Paper; Jacobs Sverdrup; 2002.
10. Dmochowski RR, Galen D. Evaluation of subacute tissue response in an animal model to evaluate a novel therapy to treat stress urinary incontinence. Presentation at the International Continence Society 30th annual meeting. Tampere, Finland; 2000.
11. Eddy DM. Clinical decision making - From theory to practice. London UK: Jones and Bartlett Publishers International; 1996.
12. Goodman C. HTA: Providing a scientific basis for the commercialization of innovative, cost-effective technologies. Panel presentation; ISTAHC 2003. Canmore, Canada; June 24, 2003.
13. Hagen A, Dintsios CM, Perleth M, et al. Methods for the assessment of premarket (pm) biomedical innovations: A systematic review. In: The challenge of collaboration. Proceedings of the 18th Annual Meeting of the International Society of Technology Assessment in Health Care, Berlin; June 2002.
14. Henley EJ, Kumamoto H. Probabilistic risk assessment. New York: IEEE Press; 1991.
15. Howard RA, Matheson JE. Influence diagrams. In: Howard RA, Matheson JE, eds. The principles and applications of decision analysis. Menlo Park CA: Strategic Decision Group; 1984.
16. Laupacis A, Boysen G, Connolly S, et al. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med. 1994;154:1449-1457.
17. Murphy DM, Paté-Cornell ME. The SAM framework: Modeling the effects of management factors on human behavior in risk analysis. Risk Anal. 1996;16:501-515.
18. Murray JW. Health technology assessment: Providing a scientific basis for the commercialization of innovative, cost-effective technologies. Panel presentation; 19th Annual Meeting of the International Society of Technology Assessment in Health Care. Canmore, Canada; June 24, 2003.
19. Obrzut SL, Hecht P, Hayashi K, Fanton GS. The effect of radiofrequency energy on the length and temperature properties of the glenohumeral joint capsule. Arthroscopy. 1998;14:395-400.
20. Pietzsch JB, Paté-Cornell ME, Krummel TM. A framework for probabilistic assessment of new medical technologies. In: Spitzer C, Schmocker U, Dang VN, eds. Probabilistic safety assessment and management (PSAM7-ESREL'04). Proceedings of the 7th International Conference on Probabilistic Safety Assessment and Management. London UK: Springer-Verlag; 2004:2224-2229.
21. Pietzsch JB. Early-stage technology assessment: Methods and opportunities. Ital J Public Health 2005;2(Suppl 1):74-75.
22. Powell NB, Riley RW, Troell RJ, et al. Radiofrequency volumetric reduction of the tongue: A porcine pilot study for the treatment of obstructive sleep apnea syndrome. Chest. 1997;111:1348-1355.
23. Powell NB, Riley RW, Troell RJ, et al. Radiofrequency volumetric tissue reduction of the palate in subjects with sleep-disordered breathing. Chest. 1998;113:1163-1174.
24. Szczepura A, Kankaanpää J. An introduction to health technology assessment. In: Szczepura A, Kankaanpää J, eds. Assessment of health care technologies: Case studies, key concepts, and strategic issues. New York: John Wiley & Sons; 1996.
25. U.S. Nuclear Regulatory Commission. Reactor safety study: An assessment of accident risks in U.S. commercial nuclear power plants. US Nuclear Regulatory Commission, NUREG-75/014; 1975.
26. U.S. Food and Drug Administration. Guidance for the use of Bayesian statistics in medical device clinical trials. Guidance Document; Washington DC: FDA CDRH; May 2006.
27. von Neumann J, Morgenstern O. Theory of games and economic behavior. 3rd ed. Princeton, NJ: Princeton University Press; 1953.